249 related articles for article (PubMed ID: 25339470)
21. Identification of potential pathogenic biomarkers in clear cell renal cell carcinoma.
Wang Z; Zhang Z; Zhang C; Xu Y
Oncol Lett; 2018 Jun; 15(6):8491-8499. PubMed ID: 29805586
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatics identification of potentially involved microRNAs in Tibetan with gastric cancer based on microRNA profiling.
Luo Y; Zhang C; Tang F; Zhao J; Shen C; Wang C; Yu P; Wang M; Li Y; Di JI; Chen R; Rili G
Cancer Cell Int; 2015; 15():115. PubMed ID: 26692821
[TBL] [Abstract][Full Text] [Related]
23. Differentially expressed miRNAs in sepsis-induced acute kidney injury target oxidative stress and mitochondrial dysfunction pathways.
Ge QM; Huang CM; Zhu XY; Bian F; Pan SM
PLoS One; 2017; 12(3):e0173292. PubMed ID: 28296904
[TBL] [Abstract][Full Text] [Related]
24. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
25. miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway.
Lee J; Kim HE; Song YS; Cho EY; Lee A
Breast Cancer Res Treat; 2019 Jul; 176(1):119-130. PubMed ID: 30989460
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy.
Zhu QN; Renaud H; Guo Y
Hereditas; 2018; 155():17. PubMed ID: 29371858
[TBL] [Abstract][Full Text] [Related]
27. Meta-microRNA Biomarker Signatures to Classify Breast Cancer Subtypes.
Oztemur Islakoglu Y; Noyan S; Aydos A; Gur Dedeoglu B
OMICS; 2018 Nov; 22(11):709-716. PubMed ID: 30388053
[TBL] [Abstract][Full Text] [Related]
28. Five miRNAs Considered as Molecular Targets for Predicting Esophageal Cancer.
Zhao JY; Wang F; Li Y; Zhang XB; Yang L; Wang W; Xu H; Liu DZ; Zhang LY
Med Sci Monit; 2015 Oct; 21():3222-30. PubMed ID: 26498375
[TBL] [Abstract][Full Text] [Related]
29. Investigation of microRNA expression profiles associated with human alcoholic cardiomyopathy.
Jing L; Jin C; Lu Y; Huo P; Zhou L; Wang Y; Tian Y
Cardiology; 2015; 130(4):223-33. PubMed ID: 25791397
[TBL] [Abstract][Full Text] [Related]
30. Identification of key miRNAs and genes associated with stomach adenocarcinoma from The Cancer Genome Atlas database.
Liu J; Liu F; Shi Y; Tan H; Zhou L
FEBS Open Bio; 2018 Feb; 8(2):279-294. PubMed ID: 29435418
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA Expression Signature in Degenerative Aortic Stenosis.
Shi J; Liu H; Wang H; Kong X
Biomed Res Int; 2016; 2016():4682172. PubMed ID: 27579316
[TBL] [Abstract][Full Text] [Related]
32. Identification of typical miRNAs and target genes in hepatocellular carcinoma by DNA microarray technique.
He TL; Zheng KL; Li G; Song B; Zhang YJ
Eur Rev Med Pharmacol Sci; 2014; 18(1):108-16. PubMed ID: 24452951
[TBL] [Abstract][Full Text] [Related]
33. Microarray analysis of microRNA expression in liver cancer tissues and normal control.
Lin L; Lin Y; Jin Y; Zheng C
Gene; 2013 Jul; 523(2):158-60. PubMed ID: 23583794
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
35. Screening miRNA and their target genes related to tetralogy of Fallot with microarray.
Wang XM; Zhang K; Li Y; Shi K; Liu YL; Yang YF; Fang Y; Mao M
Cardiol Young; 2014 Jun; 24(3):442-6. PubMed ID: 23680813
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q
BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172
[TBL] [Abstract][Full Text] [Related]
37. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
38. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
Yang Y; Mei Q
Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of the differentially expressed colorectal cancer-related microRNA expression profiles.
Li HG; Zhao LH; Bao XB; Sun PC; Zhai BP
Eur Rev Med Pharmacol Sci; 2014; 18(14):2048-57. PubMed ID: 25027346
[TBL] [Abstract][Full Text] [Related]
40. Bioinformatics analysis of miRNA expression profile between primary and recurrent glioblastoma.
Bo LJ; Wei B; Li ZH; Wang ZF; Gao Z; Miao Z
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3579-86. PubMed ID: 26502847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
